266 related articles for article (PubMed ID: 2428744)
21. Alloantisera can detect some of the variants of HLA DRw13 identified by oligotyping.
Gebuhrer L; Lambert J; Labonne MP; Mollet I; Freidel AC; Betuel H
Tissue Antigens; 1992 Jan; 39(1):42-7. PubMed ID: 1542879
[TBL] [Abstract][Full Text] [Related]
22. Identification of HLA-DRw52 associated antigens using HLA class II allogenotyping.
Savage DA; Bidwell JL; Cullen C; Bidwell EA; Middleton D
Tissue Antigens; 1988 Nov; 32(5):278-85. PubMed ID: 2464859
[TBL] [Abstract][Full Text] [Related]
23. Both HLA-DR and HLA-DQ determinants contribute to HLA-Dw typing.
Sterkers G; Zeliszewski D; Freidel AC; Gebuhrer L; Betuel H; Levy JP
Hum Immunol; 1987 Nov; 20(3):233-47. PubMed ID: 2449409
[TBL] [Abstract][Full Text] [Related]
24. RFLP analysis of HLA-DR and -DQ genes and their linkage relationships in the Pacific.
Kohonen-Corish MR; Serjeantson SW
Am J Hum Genet; 1986 Dec; 39(6):751-62. PubMed ID: 2879442
[TBL] [Abstract][Full Text] [Related]
25. Homozygous typing cell-defined HLA-Dw specificities correlate better than serologically defined HLA-DR specificities with restriction elements for influenza virus-specific proliferative human T lymphocyte clones.
Fleischer B; Pawelec G; Wernet P
Hum Immunol; 1985 Sep; 14(1):37-47. PubMed ID: 2411701
[TBL] [Abstract][Full Text] [Related]
26. Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.
Irlé C; Jaques D; Tiercy JM; Fuggle SV; Gorski J; Termijtelen A; Jeannet M; Mach B
J Exp Med; 1988 Mar; 167(3):853-72. PubMed ID: 2450955
[TBL] [Abstract][Full Text] [Related]
27. Characterization of three functional sites in alpha beta 1 DR of DRw13. All three sites are potentially involved in major histocompatibility complex-peptide interaction.
Sterkers G; Tiercy JM; Zeliszewski D; Levy JP; Mach B
Eur J Immunol; 1989 Sep; 19(9):1585-90. PubMed ID: 2529124
[TBL] [Abstract][Full Text] [Related]
28. HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.
Amar A; Mickelson E; Hansen JA; Nepom GT
Tissue Antigens; 1986 Nov; 28(5):278-87. PubMed ID: 2881380
[TBL] [Abstract][Full Text] [Related]
29. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
30. Additional complexity within the HLA-D region: sequence analysis of two new DRw13-DQw7 haplotypes.
Tiercy JM; Gebuhrer L; Freidel C; Betuel H; Mach B; Jeannet M
Hum Immunol; 1991 Oct; 32(2):95-101. PubMed ID: 1683867
[TBL] [Abstract][Full Text] [Related]
31. Functional relationships between HLA-DR2-short/FJO, DB9, and AZH as defined by DR- and DQ-restricted influenza-specific cloned T cells.
Zeliszewski D; Sterkers G; Brautbar C; Betuel H; Layrisse Z; Levy JP
Immunogenetics; 1987; 26(1-2):107-10. PubMed ID: 3497098
[No Abstract] [Full Text] [Related]
32. Definition of DRw10 specificity by restriction fragment length polymorphism.
Semana G; Bignon JD; Quillivic F; Cheneau ML; Herniou E; Muller JY; Genetet B; Fauchet R
Tissue Antigens; 1988 Sep; 32(3):113-20. PubMed ID: 2464202
[TBL] [Abstract][Full Text] [Related]
33. Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man.
Tilkin AF; Michon J; Juy D; Kayibanda M; Henin Y; Sterkers G; Betuel H; Lévy JP
J Immunol; 1987 Feb; 138(3):674-9. PubMed ID: 3492528
[TBL] [Abstract][Full Text] [Related]
34. Structural and functional variability among DQ beta alleles of DR2 subtypes.
Lee BS; Bell JI; Rust NA; McDevitt HO
Immunogenetics; 1987; 26(1-2):85-91. PubMed ID: 2886427
[TBL] [Abstract][Full Text] [Related]
35. Multiple epitopes on a single DQ molecule from the DQw3-carrying haplotypes.
Maeda H; Hirata R; Kambayashi H; Koning F; Schreuder GM
Tissue Antigens; 1986 Sep; 28(3):136-45. PubMed ID: 2431512
[TBL] [Abstract][Full Text] [Related]
36. Diversity among DRw13 DQw7 haplotypes as revealed by serology Dw typing and restriction fragment length polymorphism.
Gebuhrer L; Freidel AC; Lambert J; Labonne MP; Farre A; Betuel H
Hum Immunol; 1991 Feb; 30(2):85-90. PubMed ID: 1673674
[TBL] [Abstract][Full Text] [Related]
37. Molecular mapping class II polymorphisms in the human major histocompatibility complex. II. DQ beta.
MacMurray AJ; Bell JI; Denney D; Watling D; Foster LS; McDevitt HO
J Immunol; 1987 Jul; 139(2):574-86. PubMed ID: 2885374
[TBL] [Abstract][Full Text] [Related]
38. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes.
Sterkers G; Zeliszewski D; Chaussée AM; Deschamps I; Font MP; Freidel C; Hors J; Betuel H; Dausset J; Levy JP
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6473-7. PubMed ID: 2901099
[TBL] [Abstract][Full Text] [Related]
39. DR and DQ beta cDNA sequences associated with a DR2 haplotype.
Hurley CK; Ziff BL; Steiner N; Gregersen PK; Silver J
Hum Immunol; 1988 Jul; 22(3):179-83. PubMed ID: 3139589
[TBL] [Abstract][Full Text] [Related]
40. Allogenotypes defined by short DQ alpha and DQ beta cDNA probes correlate with and define splits of HLA-DQ serological specificities.
Bidwell JL; Bidwell EA; Laundy GJ; Klouda PT; Bradley BA
Mol Immunol; 1987 May; 24(5):513-22. PubMed ID: 2889137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
